Literature DB >> 14696103

Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.

Sophia Zackrisson1, Ingvar Andersson, Jonas Manjer, Lars Janzon.   

Abstract

Our first objective was to assess changes in non-attendance, proportion of advanced breast cancer and survival in Malmö Mammographic Service Screening Program, MMSSP, compared to a former trial, Malmö Mammographic Screening Trial, MMST. Our second objective was to describe non-attenders in MMSSP in socio-economic terms and risk for advanced breast cancer compared to attenders. Information from hospital and national registers was used to identify 33,800 women invited to service screening in MMSSP 1990-93. Attendance rates at first screening, the proportion of advanced breast cancers (Stage II-IV) and survival among non-attenders in MMSSP were compared to the non-attenders and with the control group of the former trial, MMST. Various socio-economic factors were assessed as potential predictors of non-attendance in MMSSP. Odds ratios (OR) and 95% confidence interval (CI) were computed. Incidence of breast cancer during a 10-year-period, relative risks and 95% CI among non-attenders compared to attenders in MMSSP were computed. Attendance rates were significantly lower in MMSSP but a lower proportion of advanced breast cancers and a somewhat better survival among breast cancer cases (not significant) was seen in non-attenders in MMSSP compared to MMST. In MMSSP non-attendance was associated with being unmarried, being born abroad, being not currently employed, crowded housing conditions and low income. Incidence of advanced breast cancer was significantly higher among non-attenders than among attenders. Attendance has decreased over time and potential reasons are discussed. Stage distribution and survival among non-attenders seem to have improved. Several socio-economic factors predict non-attendance and non-attenders are at higher risk for advanced breast cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14696103     DOI: 10.1002/ijc.11622

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

1.  Determinants of non-compliance to recommendations on breast cancer screening among women participating in the French E3N cohort study.

Authors:  Camille Flamant; Estelle Gauthier; Françoise Clavel-Chapelon
Journal:  Eur J Cancer Prev       Date:  2006-02       Impact factor: 2.497

2.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

Authors:  Sophia Zackrisson; Ingvar Andersson; Lars Janzon; Jonas Manjer; Jens Peter Garne
Journal:  BMJ       Date:  2006-03-03

Review 3.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

4.  Socioeconomic status as determinant for participation in mammography screening: assessing the difference between using women's own versus their partner's.

Authors:  Malin Kjellén; My von Euler-Chelpin
Journal:  Int J Public Health       Date:  2010-03-26       Impact factor: 3.380

5.  Factors affecting patient compliance in the acute setting: an analysis of 20,000 imaging reports.

Authors:  Waqas Shuaib; Arvind Vijayasarathi; Jamlik-Omari Johnson; Ninad Salastekar; Qing He; Kiran Kumar Maddu; Faisal Khosa
Journal:  Emerg Radiol       Date:  2014-03-11

6.  Estimating attendance for breast cancer screening in ethnic groups in London.

Authors:  Christine Renshaw; Ruth H Jack; Steve Dixon; Henrik Møller; Elizabeth A Davies
Journal:  BMC Public Health       Date:  2010-03-25       Impact factor: 3.295

7.  Women's patterns of participation in mammography screening in Denmark.

Authors:  My von Euler-Chelpin; Anne Helene Olsen; Sisse Njor; Ilse Vejborg; Walter Schwartz; Elsebeth Lynge
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

8.  Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women.

Authors:  Swann A Adams; Emily R Smith; James Hardin; Irene Prabhu-Das; Jeanette Fulton; James R Hebert
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

9.  Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.

Authors:  Tron A Moger; Gudrun M W Bjørnelv; Eline Aas
Journal:  Eur J Health Econ       Date:  2015-08-04

10.  The Vanguard of Community-based Integrated Care in Japan: The Effect of a Rural Town on National Policy.

Authors:  Yu Hatano; Masatoshi Matsumoto; Mitsuaki Okita; Kazuo Inoue; Keisuke Takeuchi; Takako Tsutsui; Shuhei Nishimura; Takuo Hayashi
Journal:  Int J Integr Care       Date:  2017-04-27       Impact factor: 5.120

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.